X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (26594) 26594
Newspaper Article (75) 75
Newsletter (51) 51
Book / eBook (18) 18
Magazine Article (10) 10
Book Chapter (4) 4
Conference Proceeding (2) 2
Dissertation (2) 2
Government Document (2) 2
Publication (2) 2
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21414) 21414
male (12483) 12483
female (11717) 11717
animals (9201) 9201
middle aged (8695) 8695
oncology (7287) 7287
cancer (6872) 6872
liver cancer (6542) 6542
liver (6410) 6410
aged (6392) 6392
adult (6339) 6339
mice (5628) 5628
liver neoplasms - pathology (5475) 5475
hepatocellular carcinoma (5471) 5471
carcinoma, hepatocellular - pathology (4218) 4218
liver neoplasms - immunology (4195) 4195
tumors (3881) 3881
gastroenterology & hepatology (3820) 3820
surgery (3802) 3802
immunology (3553) 3553
metastasis (3314) 3314
research article (3294) 3294
cell line, tumor (3259) 3259
medicine (3225) 3225
expression (3189) 3189
carcinoma, hepatocellular - immunology (3168) 3168
prognosis (3041) 3041
hepatoma (3030) 3030
multidisciplinary sciences (2909) 2909
analysis (2839) 2839
science (2696) 2696
liver neoplasms - metabolism (2692) 2692
liver neoplasms - genetics (2518) 2518
liver neoplasms - secondary (2515) 2515
risk factors (2375) 2375
liver neoplasms - surgery (2367) 2367
research (2334) 2334
gene expression (2312) 2312
proteins (2312) 2312
carcinoma, hepatocellular - metabolism (2285) 2285
health aspects (2271) 2271
transplantation (2250) 2250
apoptosis (2229) 2229
hepatocellular-carcinoma (2221) 2221
survival (2194) 2194
carcinoma, hepatocellular - genetics (2150) 2150
retrospective studies (2109) 2109
patients (2068) 2068
treatment outcome (2051) 2051
rats (1954) 1954
immunohistochemistry (1928) 1928
care and treatment (1917) 1917
hepatitis (1904) 1904
aged, 80 and over (1872) 1872
liver diseases (1859) 1859
cell biology (1780) 1780
medicine & public health (1758) 1758
chemotherapy (1735) 1735
liver neoplasms - therapy (1717) 1717
liver - pathology (1672) 1672
liver neoplasms - drug therapy (1660) 1660
metastases (1636) 1636
medical prognosis (1633) 1633
carcinoma, hepatocellular - surgery (1622) 1622
pathology (1567) 1567
immunotherapy (1514) 1514
rodents (1469) 1469
development and progression (1456) 1456
liver neoplasms - mortality (1445) 1445
cells (1429) 1429
digestive system diseases (1410) 1410
cell proliferation (1399) 1399
genetic aspects (1395) 1395
hepatology (1393) 1393
cirrhosis (1391) 1391
colorectal cancer (1372) 1372
gene expression regulation, neoplastic (1364) 1364
medical research (1361) 1361
therapy (1335) 1335
liver cirrhosis (1332) 1332
mice, inbred balb c (1328) 1328
liver neoplasms - diagnosis (1326) 1326
cancers and neoplasms (1325) 1325
studies (1305) 1305
diagnosis (1297) 1297
adolescent (1295) 1295
liver neoplasms - virology (1293) 1293
gastroenterology and hepatology (1277) 1277
signal transduction (1273) 1273
time factors (1266) 1266
tumor cells, cultured (1265) 1265
neoplasm transplantation (1236) 1236
biology (1227) 1227
carcinoma (1227) 1227
kinases (1227) 1227
cancer therapies (1223) 1223
carcinoma, hepatocellular - therapy (1222) 1222
carcinoma, hepatocellular - virology (1196) 1196
liver transplantation (1196) 1196
liver neoplasms - etiology (1184) 1184
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (3) 3
St. Michael's Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Online Resources - Online (1) 1
Scarborough Hospital - Birchmount (1) 1
Toronto East General Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25535) 25535
Japanese (482) 482
Chinese (432) 432
Russian (274) 274
French (190) 190
German (182) 182
Spanish (70) 70
Italian (60) 60
Polish (24) 24
Portuguese (14) 14
Hungarian (11) 11
Korean (11) 11
Romanian (10) 10
Czech (7) 7
Croatian (6) 6
Danish (6) 6
Norwegian (6) 6
Dutch (5) 5
Turkish (3) 3
Bulgarian (2) 2
Serbian (2) 2
Swedish (2) 2
Arabic (1) 1
Finnish (1) 1
Hebrew (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 676 - 681
Abstract We wanted to determine whether allogeneic hematopoietic stem cell transplantation (HSCT) may result in long-term survival in patients with solid... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Allogeneic hematopoietic stem cell transplantation | Colon carcinoma | Renal carcinoma | Cholangiocarcinoma | DONOR | BONE-MARROW | GRAFT | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | BREAST-CANCER | PRIMARY LIVER-CANCER | LEUKEMIA | HEMATOLOGY | COLON-CARCINOMA | MARROW TRANSPLANTATION | BLOOD | Adenocarcinoma - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Kidney Neoplasms - immunology | Male | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Bile Duct Neoplasms - immunology | Neoplasm Metastasis | Graft vs Host Disease - mortality | Colonic Neoplasms - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Transplantation Conditioning - methods | Graft vs Host Disease - diagnosis | Kidney Neoplasms - therapy | Colonic Neoplasms - therapy | Prostatic Neoplasms - pathology | Colonic Neoplasms - mortality | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Kidney Neoplasms - mortality | Myeloablative Agonists | Prostatic Neoplasms - mortality | Graft vs Host Disease - pathology | Bile Duct Neoplasms - therapy | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Bile Duct Neoplasms - mortality | Colonic Neoplasms - pathology | Pancreatic Neoplasms - immunology | Survival Analysis | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Aged | Bile Duct Neoplasms - pathology | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Liver cancer | Colon cancer | Pancreatic cancer | Liver | Mortality | Stem cells | Transplantation | Metastasis | Health aspects | Prostate cancer | Risk factors | Hematopoietic stem cells | College teachers
Journal Article
Breast cancer research : BCR, ISSN 1465-542X, 2015, Volume 17, Issue 1, p. 45
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 21, pp. 2691 - 2697
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremelimumab-have been... 
REGRESSION | METASTATIC MELANOMA | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | EFFICACY | ONCOLOGY | PHASE-II | MONOCLONAL-ANTIBODY | CTLA-4 | PATIENT | CANCER-IMMUNOTHERAPY | BLOCKADE | Stevens-Johnson Syndrome - immunology | Peripheral Nervous System Diseases - chemically induced | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Scleritis - chemically induced | Antineoplastic Agents - administration & dosage | Liver - immunology | Liver - drug effects | Antineoplastic Agents - adverse effects | Diarrhea - immunology | Pancreatitis - immunology | Scleritis - immunology | Mucous Membrane - drug effects | Colitis - immunology | Peripheral Nervous System Diseases - immunology | Antibodies, Monoclonal - immunology | Drug Eruptions - immunology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | CTLA-4 Antigen - drug effects | Lymphatic Diseases - immunology | Antibodies, Monoclonal - pharmacokinetics | CTLA-4 Antigen - immunology | Pancreatitis - chemically induced | Melanoma - secondary | Chemical and Drug Induced Liver Injury - immunology | Pituitary Gland - immunology | Skin Neoplasms - metabolism | Lymphatic Diseases - chemically induced | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Melanoma - immunology | Uveitis - immunology | Melanoma - drug therapy | Uveitis - chemically induced | Pituitary Gland - drug effects | Skin - drug effects | Index Medicus
Journal Article
The Journal of immunology (1950), ISSN 1550-6606, 2000, Volume 165, Issue 11, pp. 6015 - 6019
STAT4 and STAT6 are essential for the development of CD4(+) Th1 and Th2 development, respectively, Tumor immunologists have hypothesized that Th1 cells are... 
RESPONSES | INTERLEUKIN-4 | TH2 CELLS | ACTIVATOR | SUBPOPULATIONS | LYMPHOCYTE | STAT6 | DIFFERENTIATION | IMMUNOLOGY | CLASS-II | SIGNAL TRANSDUCER | Mammary Neoplasms, Experimental - immunology | Bone Marrow Neoplasms - immunology | Bone Marrow Neoplasms - genetics | Mammary Neoplasms, Experimental - genetics | STAT6 Transcription Factor | T-Lymphocytes, Cytotoxic - pathology | CD4-Positive T-Lymphocytes - immunology | Cell Differentiation - genetics | Brain Neoplasms - secondary | Brain Neoplasms - immunology | Lung Neoplasms - secondary | Neoplasm Metastasis - immunology | Cell Division - immunology | Neoplasm Metastasis - prevention & control | Mammary Neoplasms, Experimental - pathology | Trans-Activators - genetics | Liver Neoplasms - secondary | Cell Division - genetics | Liver Neoplasms - prevention & control | Lung Neoplasms - genetics | Bone Marrow Neoplasms - prevention & control | Cytotoxicity, Immunologic - genetics | Mammary Neoplasms, Experimental - prevention & control | Liver Neoplasms - genetics | Brain Neoplasms - genetics | Liver Neoplasms - immunology | Lymphatic Metastasis | Bone Marrow Neoplasms - secondary | Disease Progression | Mice, Knockout | Brain Neoplasms - prevention & control | Cell Differentiation - immunology | Neoplasm Metastasis - genetics | Lung Neoplasms - immunology | Animals | Trans-Activators - deficiency | Lung Neoplasms - prevention & control | Neoplasm Metastasis - pathology | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology
Journal Article
Gastric Cancer, ISSN 1436-3291, 1/2017, Volume 20, Issue 1, pp. 156 - 163
The microsatellite-instable gastric cancer subtype, because of its supposed high antigenic potential, is a promising candidate for immunotherapy. We analyzed... 
Chemotherapy | Prognosis | Medicine & Public Health | Mismatch repair | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | Microsatellite instability | Surgical Oncology | Gastric cancer | ADJUVANT CHEMOTHERAPY | EFFICACY | TUMOR MICROSATELLITE-INSTABILITY | BENEFIT | ONCOLOGY | COLORECTAL-CANCER | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Lung Neoplasms - drug therapy | Microsatellite Instability | Follow-Up Studies | Humans | Male | Stomach Neoplasms - pathology | DNA Mismatch Repair - genetics | Cisplatin - administration & dosage | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Fluorouracil - administration & dosage | Lung Neoplasms - secondary | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Peritoneal Neoplasms - immunology | Neutrophils - pathology | Peritoneal Neoplasms - secondary | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | Liver Neoplasms - genetics | Biomarkers, Tumor - analysis | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Survival Rate | Combined Modality Therapy | Stomach Neoplasms - drug therapy | Stomach Neoplasms - immunology | Lung Neoplasms - immunology | Lymphocytes - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - genetics | Aged | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Cancer patients | Care and treatment | Immune response | Patient outcomes | Immunotherapy | Metastasis | Stomach cancer | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 6, pp. 976 - 983
Purpose To evaluate trastuzumab (H) and docetaxel (T) with or without capecitabine (X) as first-line combination therapy for human epidermal growth factor... 
SURVIVAL | COMBINATIONS | MULTICENTER | AMPLIFICATION | THERAPY | EFFICACY | ONCOLOGY | SAFETY | PRETREATED PATIENTS | ANTIBODY | PACLITAXEL | Prognosis | Receptor, ErbB-2 - genetics | Capecitabine | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Bone Neoplasms - secondary | Soft Tissue Neoplasms - drug therapy | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Feasibility Studies | Young Adult | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Fluorouracil - analogs & derivatives | Soft Tissue Neoplasms - secondary | Deoxycytidine - administration & dosage | Liver Neoplasms - drug therapy | Soft Tissue Neoplasms - metabolism | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | International Agencies | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Liver Neoplasms - metabolism | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Trastuzumab | Liver Neoplasms | Breast Neoplasms | Life Sciences | Immunology | Taxoids | Fluorouracil | Antineoplastic Combined Chemotherapy Protocols | Antibodies, Monoclonal | Bone Neoplasms | Receptor, erbB-2 | Deoxycytidine | Soft Tissue Neoplasms
Journal Article
Journal of immunotherapy (1997), ISSN 1524-9557, 2007, Volume 30, Issue 8, pp. 825 - 830
The inhibitory receptor CTLA4 has a key role in peripheral tolerance of T cells for both normal and tumor-associated antigens. Murine experiments suggested... 
CTLA-4 | Renal cancer | Costimulation | Immunotherapy | Ipilimumab | INTERLEUKIN-2 | MEDICINE, RESEARCH & EXPERIMENTAL | renal cancer | IMMUNOLOGY | RESPONSES | MELANOMA | costimulation | ONCOLOGY | AUTOIMMUNITY | immunotherapy | ipilimumab | BLOCKADE | CARCINOMA | Lung Neoplasms - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Kidney Neoplasms - immunology | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Carcinoma, Renal Cell - immunology | Lung Neoplasms - secondary | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Hypopituitarism - chemically induced | Adult | Female | Bone Neoplasms - drug therapy | Carcinoma, Renal Cell - drug therapy | Enteritis - chemically induced | Liver Neoplasms - secondary | Pituitary Diseases - chemically induced | Carcinoma, Renal Cell - pathology | Duodenitis - chemically induced | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Treatment Outcome | Bone Neoplasms - immunology | Meningitis, Aseptic - chemically induced | Lung Neoplasms - immunology | Antibodies, Monoclonal - administration & dosage | Adrenal Insufficiency - chemically induced | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy
Journal Article
The Journal of Immunology, ISSN 0022-1767, 02/2002, Volume 168, Issue 3, pp. 1356 - 1361
We have previously implicated TNF-related apoptosis-inducing ligand (TRAIL) in innate immune surveillance against tumor development. In this study, we describe... 
DEATH DOMAIN | NKT CELLS | TRAIL | SUBPOPULATIONS | IMMUNOTHERAPY | COMPLEX CLASS-II | RECEPTOR | GENE-THERAPY | IMMUNOLOGY | EXPRESSION | MOUSE MAMMARY-TUMOR | Mammary Neoplasms, Experimental - immunology | Neoplasm Transplantation | Kidney Neoplasms - genetics | Membrane Glycoproteins - biosynthesis | Tumor Necrosis Factor-alpha - genetics | Kidney Neoplasms - immunology | Tumor Cells, Cultured - transplantation | Fibrosarcoma - immunology | Fibrosarcoma - chemically induced | Tumor Necrosis Factor-alpha - deficiency | Mammary Neoplasms, Experimental - genetics | Membrane Glycoproteins - physiology | Fibrosarcoma - pathology | TNF-Related Apoptosis-Inducing Ligand | Disease Susceptibility - immunology | Neoplasm Metastasis - immunology | Cell Division - immunology | Cell Transformation, Neoplastic - genetics | Mammary Neoplasms, Experimental - pathology | Killer Cells, Natural - immunology | Female | Adenocarcinoma - genetics | Liver Neoplasms - secondary | Cell Division - genetics | Liver Neoplasms - prevention & control | Cytotoxicity, Immunologic - genetics | Gene Targeting | Mammary Neoplasms, Experimental - prevention & control | Genetic Predisposition to Disease | Liver Neoplasms - genetics | Adenocarcinoma - immunology | Mice, Inbred C57BL | Liver Neoplasms - immunology | Methylcholanthrene - toxicity | Adenocarcinoma - secondary | Membrane Glycoproteins - genetics | Mice, Knockout | Neoplasm Metastasis - genetics | Cell Transformation, Neoplastic - immunology | Fibrosarcoma - genetics | Animals | Apoptosis Regulatory Proteins | Tumor Necrosis Factor-alpha - physiology | Ligands | Mice | Mice, Inbred BALB C | Tumor Necrosis Factor-alpha - biosynthesis | Membrane Glycoproteins - deficiency
Journal Article
PloS one, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e57911
Background: Immune evasion is one of the recognized hallmarks of cancer. Inflammatory responses to cancer can also contribute directly to oncogenesis. Since... 
BREAST-CANCER | METASTASIS | POLYMERIC IMMUNOGLOBULIN RECEPTOR | BIOMARKER | MULTIDISCIPLINARY SCIENCES | TISSUE | GENE-EXPRESSION | DOWN-REGULATION | KARYOPHERIN-ALPHA 2 | EPITHELIAL OVARIAN-CANCER | T-CELLS | Cell Adhesion Molecules - genetics | Colonic Neoplasms - genetics | Prognosis | Carcinoma, Squamous Cell - genetics | Humans | Gene Expression Regulation, Neoplastic | Databases, Genetic | Data Mining | Gene Expression Profiling | Inflammation - complications | Neoplasms - complications | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Neoplasms - genetics | Colonic Neoplasms - immunology | Adenocarcinoma - genetics | Colonic Neoplasms - mortality | Gene Expression | Adenocarcinoma - immunology | Neoplasms - mortality | Workflow | Inflammation - immunology | Carcinoma, Squamous Cell - immunology | Adenocarcinoma - complications | Colonic Neoplasms - complications | Head and Neck Neoplasms - immunology | Neoplasms - immunology | Carcinoma, Squamous Cell - complications | alpha Karyopherins - genetics | Inflammation - genetics | Head and Neck Neoplasms - complications | Head and Neck Neoplasms - genetics | Biomarkers, Tumor - genetics | Head and Neck Neoplasms - mortality | Neoplasm Staging | Adenocarcinoma - mortality | Cluster Analysis | Proteins | Immunohistochemistry | DNA microarrays | Analysis | Genes | Cancer | Ovarian cancer | Transcription factors | Ovarian carcinoma | Leukemia | Lung cancer | CXCL13 protein | Biochemistry | Genomes | Tissue analysis | Metastasis | Datasets | Liver cancer | Angiogenesis | Immunology | Colon cancer | Tumorigenesis | Colon | Neck | Protein transport | Pancreas | Bioinformatics | Immune system | Immunoglobulins | Head | Cytokines | Data processing | Inflammation | Breast cancer | CD36 antigen | Gene expression | Low level | Nuclear transport | Liquid oxygen | Biomarkers | Hypoxia | Molecular biology | Prostate | Prostate cancer
Journal Article
Molecular therapy, ISSN 1525-0016, 2015, Volume 23, Issue 3, pp. 602 - 608
Journal Article
Cancer, ISSN 0008-543X, 2016, Volume 122, Issue 21, pp. 3354 - 3362
Journal Article